Strong financial performance and growth prospects
Our financial stability, with 20 years of stable growth, and strategic vision have enabled us to secure significant long-term agreements, such as the recent partnership to supply medical devices for drug administration, including treatments for obesity and diabetes. This collaboration is expected to generate annual sales of approximately SEK 700 million within five years, underscoring our growth potential.





